Sucampo Pharmaceuticals Company Profile (NASDAQ:SCMP)

About Sucampo Pharmaceuticals

Sucampo Pharmaceuticals logoSucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on research and development of drugs to treat gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It operates through development and commercialization of pharmaceutical products segment. Its operations are conducted through Sucampo AG, based in Zug, Switzerland, through which the Company conducts certain worldwide and European operations; Sucampo Pharma, LLC, based in Tokyo and Osaka, Japan and R-Tech Ueno, Ltd., based in Kobe, Japan, through which the Company conducts its Asian operations; Sucampo Pharma Americas LLC, based in Rockville, Maryland, through which the Company conducts operations in North and South America, and Sucampo Pharma Europe, Ltd., based in Oxford, the United Kingdom. It offers AMITIZA for the treatment of constipation and RESCULA for the lowering of intraocular pressure (IOP). Its products under development include cobiprostone, RTU-1096 and RTU-009.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: SCMP
  • CUSIP: 86490910
Key Metrics:
  • Previous Close: $12.97
  • 50 Day Moving Average: $11.88
  • 200 Day Moving Average: $11.37
  • 52-Week Range: $9.59 - $22.11
  • Trailing P/E Ratio: 45.51
  • Foreward P/E Ratio: 9.98
  • P/E Growth: 1.02
  • Market Cap: $555.25M
  • Outstanding Shares: 42,810,000
  • Beta: 1.28
Profitability:
  • Net Margins: 6.65%
  • Return on Equity: 42.18%
  • Return on Assets: 11.68%
Debt:
  • Debt-to-Equity Ratio: 1.64%
  • Current Ratio: 4.27%
  • Quick Ratio: 3.89%
Additional Links:
Companies Related to Sucampo Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Sucampo Pharmaceuticals (NASDAQ:SCMP) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $19.78 (52.49% upside)
Analysts' Ratings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Show:
DateFirmActionRatingPrice TargetDetails
9/7/2016Northland SecuritiesInitiated CoverageOutperform$15.00View Rating Details
8/4/2016Jefferies GroupLower Price TargetHold$16.00 -> $14.00View Rating Details
8/4/2016MizuhoDowngradeBuy -> Neutral$13.00View Rating Details
8/1/2016Maxim GroupLower Price TargetBuy$26.00 -> $17.00View Rating Details
7/12/2016Roth CapitalReiterated RatingBuyView Rating Details
5/5/2016WallachBeth CapitalUpgradeHold -> Buy$16.00View Rating Details
5/4/2016GuggenheimReiterated RatingBuy$29.00View Rating Details
3/17/2016Leerink SwannReiterated RatingMarket Perform$17.00View Rating Details
11/6/2015HC WainwrightLower Price Target$36.00 -> $28.00View Rating Details
5/7/2015Cantor FitzgeraldDowngradeBuy -> Hold$18.00View Rating Details
3/2/2015Credit Suisse Group AGDowngradeNeutral -> Underperform$10.00 -> $13.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/3/2016Q216$0.22$0.23$48.33 million$52.00 millionViewListenView Earnings Details
5/4/2016Q116$0.19$0.21$44.11 million$47.20 millionViewListenView Earnings Details
3/8/2016Q415$0.19$0.43$42.72 million$55.40 millionViewListenView Earnings Details
11/4/2015Q315$0.18$0.16$36.18 million$33.50 millionViewListenView Earnings Details
8/5/2015Q215$0.15$0.21$31.90 million$34.90 millionViewListenView Earnings Details
5/6/2015Q114$0.14$0.14$30.19 million$29.50 millionViewListenView Earnings Details
3/4/2015Q413$0.17$0.21$37.23 million$37.80 millionViewListenView Earnings Details
11/6/2014Q313$0.04$0.03$26.11 million$31.50 millionViewListenView Earnings Details
8/5/2014Q213$0.03$0.04$24.06 million$24.10 millionViewListenView Earnings Details
5/7/2014Q113$0.04$0.02$24.19 million$22.20 millionViewListenView Earnings Details
2/26/2014Q4($0.04)$0.06$22.75 million$24.50 millionViewListenView Earnings Details
3/13/2013Q4 2012$0.12$0.32$32.21 million$34.90 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Current Year EPS Consensus Estimate: $1.03 EPS
Next Year EPS Consensus Estimate: $1.3 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.19$0.26$0.21
Q2 20165$0.20$0.29$0.25
Q3 20164$0.25$0.32$0.28
Q4 20164$0.31$0.38$0.35
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Insider Ownership Percentage: 3.31%
Institutional Ownership Percentage: 40.64%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/28/2015Daniel P. GetmanDirectorSell30,000$28.14$844,200.00View SEC Filing  
7/20/2015Thomas J KnappInsiderSell64,528$23.43$1,511,891.04View SEC Filing  
3/12/2015William AshtonDirectorSell55,762$17.55$978,623.10View SEC Filing  
3/11/2015Anthony C CelesteDirectorSell65,966$17.34$1,143,850.44View SEC Filing  
12/16/2014Cary J ClaiborneCFOSell50,000$12.91$645,500.00View SEC Filing  
12/15/2014Cary J ClaiborneCFOSell7,100$12.89$91,519.00View SEC Filing  
8/7/2014Sachiko KunoMajor ShareholderSell181,727$6.28$1,141,245.56View SEC Filing  
8/4/2014Ryuji UenoMajor ShareholderSell140,873$6.02$848,055.46View SEC Filing  
7/31/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  
7/30/2014S&R Technology Holdings, LlcMajor ShareholderSell300$6.25$1,875.00View SEC Filing  
7/25/2014Ryuji UenoMajor ShareholderSell16,155$6.26$101,130.30View SEC Filing  
7/23/2014Ryuji UenoMajor ShareholderSell5,845$6.29$36,765.05View SEC Filing  
7/22/2014S&R Technology Holdings, LlcMajor ShareholderSell2,500$6.25$15,625.00View SEC Filing  
7/21/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  
7/18/2014S&R Technology Holdings, LlcMajor ShareholderSell15,000$6.27$94,050.00View SEC Filing  
4/29/2014S&R Technology Holdings, Llcmajor shareholderSell113,600$6.65$755,440.00View SEC Filing  
4/25/2014Sachiko Kunomajor shareholderSell118,700$6.69$794,103.00View SEC Filing  
3/18/2014Gayle DolecekDirectorSell1,200$8.03$9,636.00View SEC Filing  
2/27/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  
1/17/2014Ryuji UenoCEOSell360,000$10.36$3,729,600.00View SEC Filing  
1/7/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  
10/16/2013Sachiko KunoMajor ShareholderSell360,000$6.35$2,286,000.00View SEC Filing  
9/18/2013Ryuji UenoCEOSell38,462$5.69$218,848.78View SEC Filing  
9/3/2013Ryuji UenoCEOSell38,462$5.59$215,002.58View SEC Filing  
8/19/2013Ryuji UenoCEOSell38,462$6.04$232,310.48View SEC Filing  
8/6/2013Sachiko Kunomajor shareholderSell38,462$6.21$238,849.02View SEC Filing  
7/24/2013Ryuji UenoCEOSell38,462$6.52$250,772.24View SEC Filing  
7/9/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.48$249,233.76View SEC Filing  
6/24/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.61$254,233.82View SEC Filing  
6/10/2013Sachiko KunoMajor ShareholderSell38,462$7.29$280,387.98View SEC Filing  
5/28/2013Ryuji UenoCEOSell38,462$8.79$338,080.98View SEC Filing  
5/21/2013Cary J ClaiborneCFOSell4,640$9.52$44,172.80View SEC Filing  
5/20/2013Stanley G MieleSVPSell6,400$9.60$61,440.00View SEC Filing  
5/16/2013Stanley G MieleSVPSell48,600$9.67$469,962.00View SEC Filing  
5/15/2013Timothy I MaudlinDirectorBuy32,870$9.82$322,783.40View SEC Filing  
5/13/2013Sachiko KunoMajor ShareholderSell38,462$9.27$356,542.74View SEC Filing  
2/4/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$5.22$200,771.64View SEC Filing  
12/26/2012S&R Technology Holdings, LlcMajor ShareholderSell20,262$5.01$101,512.62View SEC Filing  
11/27/2012Sachiko KunoMajor ShareholderSell12,205$5.00$61,025.00View SEC Filing  
11/13/2012Sachiko KunoMajor ShareholderSell11,962$5.00$59,810.00View SEC Filing  
11/1/2012Sachiko KunoMajor ShareholderSell37,595$5.06$190,230.70View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateHeadline
investornewswire.com logoShares Of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Expected To Hit $29 - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - September 25 at 2:22 PM
capitalcube.com logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : September 23, 2016 (NASDAQ:SCMP)
www.capitalcube.com - September 23 at 11:55 AM
News IconShares Have Ticked Up Over the Last Five Trading Sessions: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Post News (NASDAQ:SCMP)
www.kentuckypostnews.com - September 20 at 12:31 PM
investornewswire.com logoExpected For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Sales Of $267.07 - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - September 14 at 11:36 AM
News IconAnalysts Place Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Under the Lens of the Microscope - Post News (NASDAQ:SCMP)
www.kentuckypostnews.com - September 12 at 6:49 PM
capitalcube.com logoSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCMP-US : September 7, 2016 (NASDAQ:SCMP)
www.capitalcube.com - September 7 at 10:52 AM
capitalcube.com logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : September 2, 2016 (NASDAQ:SCMP)
www.capitalcube.com - September 2 at 12:06 PM
News IconShares Down for the Quarter: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Post News (NASDAQ:SCMP)
www.kentuckypostnews.com - August 28 at 11:07 AM
News IconShares Holding Above Moving Averages: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Post News (NASDAQ:SCMP)
www.kentuckypostnews.com - August 24 at 6:59 PM
investornewswire.com logoSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Reports Sales Of $51.951, Surprising Estimates By 7.759% - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - August 23 at 7:27 PM
investornewswire.com logoWill Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Hit $29 Price Target? - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - August 22 at 11:54 AM
capitalcube.com logoSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : August 22, 2016 (NASDAQ:SCMP)
www.capitalcube.com - August 22 at 11:54 AM
investornewswire.com logoAnalysts See Sales Of $267.07 For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - August 16 at 7:25 PM
capitalcube.com logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : August 15, 2016 (NASDAQ:SCMP)
www.capitalcube.com - August 15 at 7:42 PM
finance.yahoo.com logoSUCAMPO PHARMACEUTICALS, INC. Financials (NASDAQ:SCMP)
finance.yahoo.com - August 11 at 7:51 PM
capitalcube.com logoSucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:SCMP)
www.capitalcube.com - August 10 at 7:51 PM
biz.yahoo.com logoSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:SCMP)
biz.yahoo.com - August 8 at 7:32 PM
equities.com logoSucampo Pharmaceuticals Inc. (SCMP) Drops 9.43% on August 04 (NASDAQ:SCMP)
www.equities.com - August 6 at 10:01 AM
equities.com logoSucampo Pharmaceuticals Inc. (SCMP) Drops 9.43% on August 04 - Equities.com (NASDAQ:SCMP)
www.equities.com - August 5 at 7:33 PM
capitalcube.com logoSucampo Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance? (NASDAQ:SCMP)
www.capitalcube.com - August 4 at 7:47 PM
finance.yahoo.com logoEdited Transcript of SCMP earnings conference call or presentation 3-Aug-16 12:30pm GMT (NASDAQ:SCMP)
finance.yahoo.com - August 4 at 10:31 AM
finance.yahoo.com logoSucampo Pharma downgraded by Mizuho (NASDAQ:SCMP)
finance.yahoo.com - August 4 at 10:31 AM
sg.finance.yahoo.com logoSucampo reports 2Q loss (NASDAQ:SCMP)
sg.finance.yahoo.com - August 3 at 10:36 AM
publicnow.com logoSucampo Reports Second Quarter 2016 Financial Results (NASDAQ:SCMP)
www.publicnow.com - August 3 at 10:36 AM
biz.yahoo.com logoQ2 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open (NASDAQ:SCMP)
biz.yahoo.com - August 3 at 10:36 AM
biz.yahoo.com logoSucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:SCMP)
biz.yahoo.com - August 3 at 10:36 AM
publicnow.com logoPaul Edick Joins Sucampo’s Board of Directors (NASDAQ:SCMP)
www.publicnow.com - July 29 at 6:48 AM
biz.yahoo.com logoSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure (NASDAQ:SCMP)
biz.yahoo.com - July 29 at 6:36 AM
News IconHow Analysts Rated Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Last Week? - Press Telegraph (NASDAQ:SCMP)
presstelegraph.com - July 22 at 7:05 PM
investornewswire.com logoSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Expected To Post Sales Of $371.307 - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - July 21 at 7:39 PM
News IconSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SCMP)
www.engelwooddaily.com - July 21 at 7:39 PM
news.cmlviz.com logoSucampo Pharmaceuticals Inc Realized Volatility Hits A Lowered Level - CML News (NASDAQ:SCMP)
news.cmlviz.com - July 21 at 7:39 PM
News IconWill Investors Find Any Relief with Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - TGP (NASDAQ:SCMP)
telanaganapress.com - July 21 at 7:39 PM
equities.com logoSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.26% on July 20 - Equities.com (NASDAQ:SCMP)
www.equities.com - July 21 at 7:39 PM
equities.com logoSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.26% on July 20 (NASDAQ:SCMP)
www.equities.com - July 20 at 8:13 PM
finance.yahoo.com logoSucampo Announces Second Quarter 2016 Earnings Call (NASDAQ:SCMP)
finance.yahoo.com - July 20 at 6:45 AM
finance.yahoo.com logoThis Impressive Small-Cap Pharma Is Set For Its Next Big Move (NASDAQ:SCMP)
finance.yahoo.com - July 19 at 1:30 PM
ftsenews.co.uk logoNew Broker Ratings For Sucampo Pharmaceuticals, Inc. (SCMP) - FTSE News (NASDAQ:SCMP)
www.ftsenews.co.uk - July 19 at 8:25 AM
News IconShares Moving Down on the Week: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Engelwood Daily (NASDAQ:SCMP)
www.engelwooddaily.com - July 18 at 12:53 PM
investornewswire.com logoStrong Sell Calls For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) At 0 - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - July 18 at 12:53 PM
News IconShare Performance Summary for: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Press Telegraph (NASDAQ:SCMP)
presstelegraph.com - July 18 at 12:53 PM
News IconSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:SCMP)
telanaganapress.com - July 18 at 12:53 PM
capitalcube.com logoSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : July 18, 2016 (NASDAQ:SCMP)
www.capitalcube.com - July 18 at 8:24 AM
News IconSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:SCMP)
www.engelwooddaily.com - July 14 at 10:55 AM
zacks.com logoSucampo to Stop Developing Cobiprostone for Oral Mucositis (NASDAQ:SCMP)
www.zacks.com - July 12 at 7:34 PM
biz.yahoo.com logoSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:SCMP)
biz.yahoo.com - July 12 at 6:31 AM
News IconWall Street Ratings and Target Price Views on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Telanagana Press (NASDAQ:SCMP)
telanaganapress.com - July 11 at 7:14 PM
investornewswire.com logoIs $29 Within Reach For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)? - Investor Newswire (NASDAQ:SCMP)
www.investornewswire.com - July 11 at 7:14 PM
streetinsider.com logoSucampo Pharma (SCMP) to Discontinue Cobiprostone Development Following Phase 2a Results - StreetInsider.com (NASDAQ:SCMP)
www.streetinsider.com - July 11 at 7:14 PM
biz.yahoo.com logoSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:SCMP)
biz.yahoo.com - July 11 at 10:34 AM

Social

Sucampo Pharmaceuticals (NASDAQ:SCMP) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff